Javascript must be enabled to continue!
Abstract 4407: Taurine's potential role in tamoxifen resistant MCF-7 cells
View through CrossRef
Abstract
Taurine is a non-proteinogenic amino acid synthesized from cysteine. Although taurine does not contribute to protein synthesis, it regulates glutathione metabolism, upregulates proliferative and anti-oxidative pathways, downregulates pro-apoptotic pathways, and improves mitochondrial function in normal tissues. However, the role of taurine in tumorigenesis and resistance development in cancer, especially breast cancer, is not widely understood. We aim to study metabolic and cellular changes associated with the taurine metabolism pathway in tamoxifen resistant (TAM-R) MCF-7 breast cancer cell lines. Methods: Three TAM-R MCF-7 models were developed using two strategies. The first was achieved by incrementally increasing the dose until reaching a predetermined dose (TAM-P). The second was achieved by taking cell lines from the first method and continuously treating them with 1μM of tamoxifen (TAM-C). NMR was used to quantify the levels of intracellular metabolites, and HPLC/MS-MS was used to calculate taurine uptake by the cells from media. Gene expression levels of ESR1, PI3KCA and PTEN were measured by RT-PCR. GSCA: Gene Set Cancer Analysis platform was used to check the association of a gene set consisting of taurine metabolism pathway genes (CDO1, ADO, GAD1, GAD2, CSAD) with the regulation of cancer related pathways. Results: Taurine, choline, and glutathione concentrations were significantly higher in TAM-C compared to tamoxifen-sensitive control and TAM-P, while cystine was lower in TAM-C. Taurine uptake from the media in TAM-C and control were slightly higher than TAM-P. ESR1 was 40 folds overexpressed in TAM-C and down regulated in TAM-P, while PI3KCA was overexpressed and PTEN was down regulated in both TAM-C and TAM-P. Moreover, there was a positive correlation between taurine metabolism pathway gene set and activation of ER pathway. Conclusion: The significant increase in taurine and decrease in cysteine in the TAM-C group cannot be explained by the marginal increase in taurine uptake alone, which necessities increased synthesis of the taurine. Overexpression of ESR1 in TAM-C could be caused by upregulation of the taurine synthesis pathway. However, overexpression of PI3KCA and down regulation of PTEN indicates reliance on PI3K/AKT/PTEN pathway instead of estrogen signaling pathway. Moreover, increased glutathione and choline concentrations increased antioxidative capacity, mitochondrial function, and resistance to oxidative stress.
Citation Format:
Yazan I. Hamadneh, Mohammad Alwahsh, Aya Hasan, Ala A. Alhusban, Osama M. Younis, Roland Hergenröder, Lama Hamadneh. Taurine's potential role in tamoxifen resistant MCF-7 cells [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2025; Part 1 (Regular Abstracts); 2025 Apr 25-30; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2025;85(8_Suppl_1):Abstract nr 4407.
American Association for Cancer Research (AACR)
Title: Abstract 4407: Taurine's potential role in tamoxifen resistant MCF-7 cells
Description:
Abstract
Taurine is a non-proteinogenic amino acid synthesized from cysteine.
Although taurine does not contribute to protein synthesis, it regulates glutathione metabolism, upregulates proliferative and anti-oxidative pathways, downregulates pro-apoptotic pathways, and improves mitochondrial function in normal tissues.
However, the role of taurine in tumorigenesis and resistance development in cancer, especially breast cancer, is not widely understood.
We aim to study metabolic and cellular changes associated with the taurine metabolism pathway in tamoxifen resistant (TAM-R) MCF-7 breast cancer cell lines.
Methods: Three TAM-R MCF-7 models were developed using two strategies.
The first was achieved by incrementally increasing the dose until reaching a predetermined dose (TAM-P).
The second was achieved by taking cell lines from the first method and continuously treating them with 1μM of tamoxifen (TAM-C).
NMR was used to quantify the levels of intracellular metabolites, and HPLC/MS-MS was used to calculate taurine uptake by the cells from media.
Gene expression levels of ESR1, PI3KCA and PTEN were measured by RT-PCR.
GSCA: Gene Set Cancer Analysis platform was used to check the association of a gene set consisting of taurine metabolism pathway genes (CDO1, ADO, GAD1, GAD2, CSAD) with the regulation of cancer related pathways.
Results: Taurine, choline, and glutathione concentrations were significantly higher in TAM-C compared to tamoxifen-sensitive control and TAM-P, while cystine was lower in TAM-C.
Taurine uptake from the media in TAM-C and control were slightly higher than TAM-P.
ESR1 was 40 folds overexpressed in TAM-C and down regulated in TAM-P, while PI3KCA was overexpressed and PTEN was down regulated in both TAM-C and TAM-P.
Moreover, there was a positive correlation between taurine metabolism pathway gene set and activation of ER pathway.
Conclusion: The significant increase in taurine and decrease in cysteine in the TAM-C group cannot be explained by the marginal increase in taurine uptake alone, which necessities increased synthesis of the taurine.
Overexpression of ESR1 in TAM-C could be caused by upregulation of the taurine synthesis pathway.
However, overexpression of PI3KCA and down regulation of PTEN indicates reliance on PI3K/AKT/PTEN pathway instead of estrogen signaling pathway.
Moreover, increased glutathione and choline concentrations increased antioxidative capacity, mitochondrial function, and resistance to oxidative stress.
Citation Format:
Yazan I.
Hamadneh, Mohammad Alwahsh, Aya Hasan, Ala A.
Alhusban, Osama M.
Younis, Roland Hergenröder, Lama Hamadneh.
Taurine's potential role in tamoxifen resistant MCF-7 cells [abstract].
In: Proceedings of the American Association for Cancer Research Annual Meeting 2025; Part 1 (Regular Abstracts); 2025 Apr 25-30; Chicago, IL.
Philadelphia (PA): AACR; Cancer Res 2025;85(8_Suppl_1):Abstract nr 4407.
Related Results
miR-449a Suppresses Tamoxifen Resistance in Human Breast Cancer Cells by Targeting ADAM22
miR-449a Suppresses Tamoxifen Resistance in Human Breast Cancer Cells by Targeting ADAM22
Background/Aims: Most of estrogen receptor positive breast cancer patients respond well initially to endocrine therapies, but often develop resistance during treatment with selecti...
Dual targeting of EphA2 and ER restores tamoxifen sensitivity in ER/EphA2-positive breast cancer.
Dual targeting of EphA2 and ER restores tamoxifen sensitivity in ER/EphA2-positive breast cancer.
Abstract
Abstract #3020
Background: Overexpression and altered function of EphA2 receptor tyrosine kinase are critical in the progression of breast ca...
Taurine inhibits osteoblastic differentiation of aortic valve interstitial cells induced by beta-glycerophosphate, dexamethasone and ascorbic acid via the ERK pathway
Taurine inhibits osteoblastic differentiation of aortic valve interstitial cells induced by beta-glycerophosphate, dexamethasone and ascorbic acid via the ERK pathway
Purpose
Aortic valve calcification (AVC) has been recognised as an active process characterised by osteoblastic differentiation of the aortic valve interstitial c...
Risk of Death Due to Breast Cancer in Women Treated with Selective Serotonin Reuptake Inhibitor Antidepressants and Tamoxifen.
Risk of Death Due to Breast Cancer in Women Treated with Selective Serotonin Reuptake Inhibitor Antidepressants and Tamoxifen.
Abstract
Background: Tamoxifen is widely prescribed to women with breast cancer, but is a prodrug converted by cytochrome P450 2D6 (CYP 2D6) to its active metabolite...
Taurine reabsorption by a carrier interacting with furosemide in short and long Henle's loops of rat nephrons
Taurine reabsorption by a carrier interacting with furosemide in short and long Henle's loops of rat nephrons
Taurine is net reabsorbed in the proximal convolution by Cl- -stimulated Na+ symport specific for beta-amino acids but not in later nephron segments. However, large unidirectional ...
Abstract 1738: Histone deacetylase inhibitor mediated reversal of acquired endocrine therapy resistance in breast cancer cell lines
Abstract 1738: Histone deacetylase inhibitor mediated reversal of acquired endocrine therapy resistance in breast cancer cell lines
Abstract
Although nearly 70% of breast cancers are estrogen receptor (ER) positive, endocrine therapy using the selective ER modulator tamoxifen or the selective ER ...
International Breast Cancer Study Group (IBCSG)
International Breast Cancer Study Group (IBCSG)
This section provides current contact details and a summary of recent or ongoing clinical trials being coordinated by International Breast Cancer Study Group (IBCSG). Clinical tria...
Abstract 3902: Glutathione as a potential marker of tamoxifen resistance in breast cancer
Abstract 3902: Glutathione as a potential marker of tamoxifen resistance in breast cancer
Abstract
Glutathione (GSH) is an antioxidant with an important protective intracellular role against reactive oxygen species. Increased glutathione level is associat...

